Global Perspectives in Gastrointestinal Malignancies (WCGI)

Latest therapeutic developments in GI cancer treatment and implications on individualized clinical decision-making. How will emerging data shape future treatment paradigms?

July 10 and 11, 2023
Howard Hochster, MD, FACP, Aptitude Health Scientific Leader

Faculty Chair

Howard S. Hochster, MD, FACP

Rutgers Cancer Institute of New Jersey

Faculty Members

Dirk Arnold, MD, PhD
University of Hamburg, Germany

Dominik Modest, MD
University of Munich, Germany

Gerald Prager, MD, PhD
University of Vienna, Austria

Julien Taieb, MD, PhD
University of Paris, France

Efrat Dotan, MD
Fox Chase Cancer Center, Philadelphia, PA, USA

Tanios Bekaii-Saab, MD, FACP
Mayo Clinic Cancer Center, Phoenix, AZ, USA

Scott Kopetz, MD, PhD, FACP
MD Anderson Cancer Center, Houston, TX, USA

Christopher Lieu, MD
University of Colorado Cancer Center, Aurora, CO, USA


Download the meeting agenda

View Agenda

Sample Report

Start discovering the insights

View Report


  • Metastatic Colorectal Cancer – Chemotherapy, Targeted Therapies, and Biomarker-Driven Treatments
  • Metastatic Colorectal Cancer – Immunotherapy
  • Rectal Cancer
  • Gastroesophageal Junction (GEJ) and Gastric Cancer
  • Hepatocellular Carcinoma (HCC)
  • Pancreatic Cancer and Biliary Tract Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.